Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moses Elisaf

Showing results (1-10 of 248) with videos related to

Pageof 25
Sort By:
Current Medical Research and Opinion|September 21, 2002
Effects of fibrates on serum metabolic parametersMoses Elisaf
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 1, 2003
Fibrates and C-reactive proteinAngeliki Kostoula, Moses Elisaf
Archives of Medical Science : AMS|August 7, 2014
Nicotinic acid/laropiprant reduces platelet count but increases mean platelet volume in patients with primary dyslipidemiaAnastazia Kei, Moses Elisaf
Current Medical Research and Opinion|July 2, 2011
Multifactorial treatment for improvement of renal function and cardiovascular risk: an ATTEMPT for patients with metabolic syndrome and chronic kidney diseaseNiki Katsiki, Moses Elisaf
Current Medical Research and Opinion|June 13, 2017
Vorapaxar in secondary prevention: where we standAnastazia Kei, Moses Elisaf
Current Medicinal Chemistry|April 18, 2017
Incretins and Lipid MetabolismVasilis Tsimihodimos, Moses Elisaf
Journal of Medical Case Reports|July 1, 2011
Native valve endocarditis due to Micrococcus luteus: a case report and review of the literatureGeorge Miltiadous, Moses Elisaf
Current Medical Research and Opinion|October 12, 2017
National hyperlipidemia management policies improve lipid target attainment in clinical practiceFotios Barkas, Moses Elisaf
Angiology|November 8, 2017
Serum Potassium Levels and Mortality in Acute Myocardial Infarction: Myth or Fact?Fotios Barkas, Moses Elisaf
Current Opinion in Lipidology|April 6, 2011
Lipoprotein glomerulopathyVasilis Tsimihodimos, Moses Elisaf
Pageof 25

Showing results (1-10 of 248) with videos related to

Sort By:
Pageof 25
Current Medical Research and Opinion|September 21, 2002
Effects of fibrates on serum metabolic parametersMoses Elisaf
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 1, 2003
Fibrates and C-reactive proteinAngeliki Kostoula, Moses Elisaf
Archives of Medical Science : AMS|August 7, 2014
Nicotinic acid/laropiprant reduces platelet count but increases mean platelet volume in patients with primary dyslipidemiaAnastazia Kei, Moses Elisaf
Current Medical Research and Opinion|July 2, 2011
Multifactorial treatment for improvement of renal function and cardiovascular risk: an ATTEMPT for patients with metabolic syndrome and chronic kidney diseaseNiki Katsiki, Moses Elisaf
Current Medical Research and Opinion|June 13, 2017
Vorapaxar in secondary prevention: where we standAnastazia Kei, Moses Elisaf
Current Medicinal Chemistry|April 18, 2017
Incretins and Lipid MetabolismVasilis Tsimihodimos, Moses Elisaf
Journal of Medical Case Reports|July 1, 2011
Native valve endocarditis due to Micrococcus luteus: a case report and review of the literatureGeorge Miltiadous, Moses Elisaf
Current Medical Research and Opinion|October 12, 2017
National hyperlipidemia management policies improve lipid target attainment in clinical practiceFotios Barkas, Moses Elisaf
Angiology|November 8, 2017
Serum Potassium Levels and Mortality in Acute Myocardial Infarction: Myth or Fact?Fotios Barkas, Moses Elisaf
Current Opinion in Lipidology|April 6, 2011
Lipoprotein glomerulopathyVasilis Tsimihodimos, Moses Elisaf
Pageof 25